[心理药物治疗的性别特异性方面]
Georgios Schoretsanitis1,2, Chiara T Schmidt3, Michael Paulzen4,5
1Psychiatrische Universitätsklinik Zürich (PUK), Zürich, Schweiz.
Der Nervenarzt
|December 1, 2025
概括
由于药理动力学和药理动力学方面的差异,性别差异对精神药物有效性和安全性有重大影响. 考虑这些因素和生命阶段对于优化心理健康治疗至关重要.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
背景情况:
- 目前关于精神药物治疗的指导方针往往忽视了性别特异性的差异.
- 男性和女性患者对心理药物的反应可能不同.
- 这些差异源于药理动力学和药理动力学方面的差异.
研究的目的:
- 提供心理药物药理动学的性别特异性的概述.
- 解决影响药物反应的生命阶段依赖性变化.
- 突出治疗药物监测 (TDM) 在优化治疗中的作用.
主要方法:
- 对心理药物的性别特异性药理动力学现有文献的综述.
- 分析不同生命阶段 (月经,口服避孕药,怀孕,更年期) 的生理变化.
- 讨论治疗药物监测 (TDM) 的实用性.
主要成果:
- 在精神药物如何被吸收,分配,代谢和分泌方面存在显著的基于性别的差异.
- 诸如月经,口服避孕药的使用,怀孕和更年期等生理事件深刻地改变了药物的药理动力学.
- 这些药物动力学转变需要个性化的治疗方法.
结论:
- 在治疗指南中,承认和整合特定于性别和生命阶段的考虑是必不可少的.
- 治疗药物监测 (TDM) 是管理药物动力学变化的宝贵工具.
- 优化心理药物药物治疗需要一个个性化的方法,考虑到个体的生物学差异.
相关概念视频
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
180
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
180
01:28Drug Therapy
232
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
232
01:27Panic Disorder
585
Panic disorder is an anxiety disorder characterized by recurrent and sudden minutes-long episodes of intense fear, known as panic attacks. These attacks may feel like heart attacks and often happen without warning or a specific cause. They can include symptoms such as rapid heart rate, shortness of breath, chest pain, trembling, sweating, dizziness, and a sense of helplessness. During a panic attack, individuals may feel as though they are experiencing a heart attack or are in a...
585
01:21Factors Affecting Drug Response: Overview
2.8K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.8K
01:15Drug Dosing: Geriatric Patients
212
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
212
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
241
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
241